EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study

Junfang Cui, Yunfeng Liu, Mina Li, Jianhong Yin, Jing Yang, Linxin Xu

BMC Endocrine Disorders · 2024

DOI: 10.1186/s12902-024-01560-1 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Junfang Cui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Hospital of Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanxi Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To explore the association of serum asprosin levels with metabolic dysfunction-associated fatty liver disease (MAFLD) in older adults with type 2 diabetes mellitus (T2DM).

Methods

The cross-sectional study enrolled patients ≥ 65 years old diagnosed with T2DM at two community health service centers between November 2019 and July 2021. Logistic regression was applied to analyze the influencing factors of MAFLD.

Results

Totally 219 cases were included. Compared with diabetic individuals without MAFLD ( n = 105), diabetics with MAFLD ( n = 114) had younger ages, higher body mass index values, shorter time from T2DM diagnosis, increased waist-to-hip ratios, elevated triglycerides, reduced high-density lipoprotein cholesterol (HDL-C), elevated alanine aminotransferase (ALT), elevated γ-glutaryl transferase, elevated fasting insulin, and elevated HOMA-IR (all P < 0.05). Serum asprosin levels were elevated in diabetics with MAFLD in comparison with the non-MAFLD group (291.71 ± 73.69 vs. 255.24 ± 82.52 pg/ml, P = 0.001). Multivariable analysis revealed, after adjusted for age, time from T2DM diagnosis, HDL-C, and ALT, serum asprosin level (OR = 1.006, 95%CI: 1.001–1.010, P = 0.014) were independently associated with MAFLD in T2DM.

Conclusions

High asprosin level are associated with MAFLD in older patients with T2DM, after adjusted for age, time from T2DM diagnosis, WHR, TG, HDL-C, ALT, GGT, FINS, and HOMA-IR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseAgedHumansBody Mass IndexCholesterol, HDLCross-Sectional StudiesAdipokinesFibrillin-1

Stichwörter der Autor:innen

AsprosinBlood biomarkerMetabolic dysfunction-associated fatty liver diseaseScreeningType 2 diabetes mellitus

Substanzen

Cholesterol, HDLFBN1 protein, humanAdipokinesFibrillin-1

Autor:innen und Institutionen

  • Department of Geriatrics, The First Hospital of Shanxi Medical University, Taiyuan, China.
  • Department of Endocrinology, The First Hospital of Shanxi Medical University, Taiyuan, China.
  • Department of Endocrinology, The First Hospital of Shanxi Medical University, Taiyuan, China. yangjlm@126.com.
  • Shanxi Medical University, Taiyuan, China. yangjlm@126.com.
  • Department of Endocrinology, The First Hospital of Shanxi Medical University, Taiyuan, China. xulinxin_518@163.com.

Förderung

  • Shanxi Provincial Health Commission

Zitieren

APA

Cui, J., Liu, Y., Li, M., Yin, J., Yang, J., & Xu, L. (2024). Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01560-1

Vancouver

Cui J, Liu Y, Li M, Yin J, Yang J, Xu L. Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01560-1

BibTeX
@article{Cui2024,
  author = {Cui, Junfang and Liu, Yunfeng and Li, Mina and Yin, Jianhong and Yang, Jing and Xu, Linxin},
  title = {Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study},
  journal = {BMC Endocrine Disorders},
  year = {2024},
  doi = {10.1186/s12902-024-01560-1}
}
Kostenlos starten →